GGrantIndex
Sort

172,184 grants matching inflammation

Computer Integrated Systems for Microscopy&Manipulation

$850,922
Richard Superfine · Univ Of North Carolina Chapel Hill · P41 · FY2008 · EB

Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes

$850,868
George L King · Joslin Diabetes Center · R01 · FY2022 · HL

IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS

$850,811
David Sacks · Niaid Extramural Activities · Z01 · FY2007 · AI

Dual Targeting of Mtb Resistance Mechanisms

$850,750
Christoph Grundner · Seattle Children'S Hospital · R01 · FY2020 · AI

Influence of HIV infection on vaginal virome and risk of preterm birth in pregnant South African women

$850,737
Heather Beryl Jaspan · Seattle Children'S Hospital · R01 · FY2023 · HD

Activation of probiotic bifidobacteria by milk glyans

$850,712
David Andrew Mills · University Of California At Davis · R01 · FY2016 · AT

Biobehavioral Predictors of Illness Progression in Adolescent Depression

$850,634
Vilma Gabbay · Albert Einstein College Of Medicine · R01 · FY2020 · MH

PRSS1 Mutation and Pancreatic Cancer Tumorigenesis

$850,552
Baoan Ji · Mayo Clinic Jacksonville · R01 · FY2025 · CA

VERMONT IMMUNOBIOL/INFECTIOUS DIS CTR: CORE A: ADMINISTRATIVE/INTELLECTUAL CORE

$850,538
Ralph C. Budd · University Of Vermont & St Agric College · P20 · FY2010 · RR

Effects of experimentally-induced reductions in alcohol consumption on brain cognitive, and clinical outcomes and motivation for changing drinking in older persons with HIV infection

$850,538
Robert L Cook · University Of Florida · U01 · FY2017 · AA

Development and non-clinical GLP testing of a new anti-arteriosclerosis gene therapy delivered by engineered adeno-associated viral vectors.

$850,531
Maurizio Chiriva-Internati · Kiromic, Inc. · R42 · FY2018 · HL

Preclinical Mouse Models of Thyroid Cancer

$850,417
Sheue-Yann Cheng · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

A Systems-level Approach to Studying HIV/AIDS Susceptibility and Substance Abuse

$850,377
Steven M Wolinsky · Northwestern University At Chicago · R01 · FY2016 · DA

Improving Outcomes Assessment in Chronic Graft versus Host Disease

$850,326
Stephanie J Lee · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA

Basic Research Support for the CCR

$850,265
Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA

Developing a Sickle Africa Data Coordinating Center (SADaCC)

$850,264
Ambroise Wonkam · University Of Cape Town · U24 · FY2017 · HL

Process Development and Preclinical Advancement of a Novel Nanoparticle Formulation for Immune Activation

$850,188
Richard Johnson · Saros Therapeutics Inc · R44 · FY2024 · CA

Targeting MMP9 to Improve Outcomes in Serious Influenza Infections

$850,154
Kevin S Harrod · University Of Alabama At Birmingham · R01 · FY2018 · AI

DYNAMICS AND TUNING OF THE MHC II PRESENTED PEPTIDOME

$850,132
Laura Santambrogio · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · AI

Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis

$850,059
Carlos Fernandez Hernando · Yale University · R35 · FY2022 · HL

Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis

$850,059
Carlos Fernandez Hernando · Yale University · R35 · FY2021 · HL

Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis

$850,059
Carlos Fernandez Hernando · Yale University · R35 · FY2020 · HL

Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis

$850,059
Carlos Fernandez Hernando · Yale University · R35 · FY2017 · HL

Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis

$850,059
Carlos Fernandez Hernando · Yale University · R35 · FY2023 · HL

Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis

$850,059
Carlos Fernandez Hernando · Yale University · R35 · FY2019 · HL